Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

Towards Novel Photodynamic Anticancer Agents Generating Superoxide Anion Radicals: A Cyclometalated IrIII Complex Conjugated to a Far-Red Emitting Coumarin.

Novohradsky V, Rovira A, Hally C, Galindo A, Vigueras G, Gandioso A, Svitelova M, Bresolí-Obach R, Kostrhunova H, Markova L, Kasparkova J, Nonell S, Ruiz J, Brabec V, Marchán V.

Angew Chem Int Ed Engl. 2019 Mar 19. doi: 10.1002/anie.201901268. [Epub ahead of print]

PMID:
30889300
2.

Cyclometalated iridium(iii) complexes as lysosome-targeted photodynamic anticancer and real-time tracking agents.

He L, Li Y, Tan CP, Ye RR, Chen MH, Cao JJ, Ji LN, Mao ZW.

Chem Sci. 2015 Oct 1;6(10):5409-5418. doi: 10.1039/c5sc01955a. Epub 2015 Jul 22.

3.

Dual Functions of Cyclometalated Iridium(III) Complexes: Anti-Metastasis and Lysosome-Damaged Photodynamic Therapy.

Wang FX, Chen MH, Lin YN, Zhang H, Tan CP, Ji LN, Mao ZW.

ACS Appl Mater Interfaces. 2017 Dec 13;9(49):42471-42481. doi: 10.1021/acsami.7b10258. Epub 2017 Nov 28.

PMID:
29140069
4.

Cyclometalated Iridium(III)-Complex-Based Micelles for Glutathione-Responsive Targeted Chemotherapy and Photodynamic Therapy.

Xiang H, Chen H, Tham HP, Phua SZF, Liu JG, Zhao Y.

ACS Appl Mater Interfaces. 2017 Aug 23;9(33):27553-27562. doi: 10.1021/acsami.7b09506. Epub 2017 Aug 9.

PMID:
28749655
5.

Mitochondria-targeting cyclometalated iridium(III)-PEG complexes with tunable photodynamic activity.

Li SP, Lau CT, Louie MW, Lam YW, Cheng SH, Lo KK.

Biomaterials. 2013 Oct;34(30):7519-32. doi: 10.1016/j.biomaterials.2013.06.028. Epub 2013 Jul 9.

PMID:
23849346
6.

AcetylacetonateBODIPY-Biscyclometalated Iridium(III) Complexes: Effective Strategy towards Smarter Fluorescent Photosensitizer Agents.

Palao E, Sola-Llano R, Tabero A, Manzano H, Agarrabeitia AR, Villanueva A, López-Arbeloa I, Martínez-Martínez V, Ortiz MJ.

Chemistry. 2017 Jul 26;23(42):10139-10147. doi: 10.1002/chem.201701347. Epub 2017 Jul 6.

PMID:
28543812
7.
8.

Mixed-ligand iridium(iii) complexes as photodynamic anticancer agents.

Zheng Y, He L, Zhang DY, Tan CP, Ji LN, Mao ZW.

Dalton Trans. 2017 Aug 29;46(34):11395-11407. doi: 10.1039/c7dt02273e.

PMID:
28813052
9.

Strong Influence of the Ancillary Ligand over the Photodynamic Anticancer Properties of Neutral Biscyclometalated IrIII Complexes Bearing 2-Benzoazole-Phenolates.

Martínez-Alonso M, Busto N, Aguirre LD, Berlanga L, Carrión MC, Cuevas JV, Rodríguez AM, Carbayo A, Manzano BR, Ortí E, Jalón FA, García B, Espino G.

Chemistry. 2018 Nov 27;24(66):17523-17537. doi: 10.1002/chem.201803784. Epub 2018 Nov 2.

PMID:
30176086
10.

Cyclometalated iridium(iii) N-heterocyclic carbene complexes as potential mitochondrial anticancer and photodynamic agents.

Li Y, Liu B, Lu XR, Li MF, Ji LN, Mao ZW.

Dalton Trans. 2017 Aug 29;46(34):11363-11371. doi: 10.1039/c7dt01903c.

PMID:
28812748
12.

Thiabendazole-based Rh(III) and Ir(III) biscyclometallated complexes with mitochondria-targeted anticancer activity and metal-sensitive photodynamic activity.

Pérez-Arnaiz C, Acuña MI, Busto N, Echevarría I, Martínez-Alonso M, Espino G, García B, Domínguez F.

Eur J Med Chem. 2018 Sep 5;157:279-293. doi: 10.1016/j.ejmech.2018.07.065. Epub 2018 Aug 2.

PMID:
30099251
13.

A Cyclometalated IrIII Complex as a Lysosome-Targeted Photodynamic Therapeutic Agent for Integrated Imaging and Therapy in Cancer Cells.

Sudheesh KV, Jayaram PS, Samanta A, Bejoymohandas KS, Jayasree RS, Ajayaghosh A.

Chemistry. 2018 Aug 1;24(43):10999-11007. doi: 10.1002/chem.201801918. Epub 2018 Jul 10.

PMID:
29806867
14.

Photoluminescence properties of a novel cyclometalated iridium(III) complex with coumarin-boronate and its recognition of hydrogen peroxide.

Li C, Wang S, Huang Y, Wen Q, Wang L, Kan Y.

Dalton Trans. 2014 Apr 14;43(14):5595-602. doi: 10.1039/c3dt53498g.

PMID:
24549180
15.

Photochemical Properties of Red-Emitting Tris(cyclometalated) Iridium(III) Complexes Having Basic and Nitro Groups and Application to pH Sensing and Photoinduced Cell Death.

Kando A, Hisamatsu Y, Ohwada H, Itoh T, Moromizato S, Kohno M, Aoki S.

Inorg Chem. 2015 Jun 1;54(11):5342-57. doi: 10.1021/acs.inorgchem.5b00369. Epub 2015 May 15.

PMID:
25978770
16.

Iridium(iii) complexes with five-membered heterocyclic ligands for combined photodynamic therapy and photoactivated chemotherapy.

Wu N, Cao JJ, Wu XW, Tan CP, Ji LN, Mao ZW.

Dalton Trans. 2017 Oct 10;46(39):13482-13491. doi: 10.1039/c7dt02477k.

PMID:
28951916
17.

N-Heterocyclic carbenes: versatile second cyclometalated ligands for neutral iridium(III) heteroleptic complexes.

Li TY, Liang X, Zhou L, Wu C, Zhang S, Liu X, Lu GZ, Xue LS, Zheng YX, Zuo JL.

Inorg Chem. 2015 Jan 5;54(1):161-73. doi: 10.1021/ic501949h. Epub 2014 Dec 11.

PMID:
25495711
18.

Exploring the Effect of Polypyridyl Ligands on the Anticancer Activity of Phosphorescent Iridium(III) Complexes: From Proteosynthesis Inhibitors to Photodynamic Therapy Agents.

Pracharova J, Vigueras G, Novohradsky V, Cutillas N, Janiak C, Kostrhunova H, Kasparkova J, Ruiz J, Brabec V.

Chemistry. 2018 Mar 26;24(18):4607-4619. doi: 10.1002/chem.201705362. Epub 2018 Feb 27.

PMID:
29369444
19.

Design and Synthesis of Amphiphilic and Luminescent Tris-Cyclometalated Iridium(III) Complexes Containing Cationic Peptides as Inducers and Detectors of Cell Death via a Calcium-Dependent Pathway.

Hisamatsu Y, Shibuya A, Suzuki N, Suzuki T, Abe R, Aoki S.

Bioconjug Chem. 2015 May 20;26(5):857-79. doi: 10.1021/acs.bioconjchem.5b00095. Epub 2015 May 5.

PMID:
25875312
20.

Achieving efficient photodynamic therapy under both normoxia and hypoxia using cyclometalated Ru(ii) photosensitizer through type I photochemical process.

Lv Z, Wei H, Li Q, Su X, Liu S, Zhang KY, Lv W, Zhao Q, Li X, Huang W.

Chem Sci. 2017 Oct 31;9(2):502-512. doi: 10.1039/c7sc03765a. eCollection 2018 Jan 14.

Supplemental Content

Support Center